
22Neuro is a franchise brand in the Clinics & Nursing Homes sector in India, established in 2023 and franchising since 2024. A new unit needs an investment of ₹1 Cr - 2 Cr and 1000 - 35000 sq ft of space. It has less than 10 outlets and is headquartered in Pune, Maharashtra. The brand is expanding in Andaman and Nicobar Islands, Andhra Pradesh and Arunachal Pradesh and 32 more locations.
| Total investment | ₹1 Cr - 2 Cr |
|---|---|
| Unit franchise investment | ₹1 Cr - 2 Cr |
| Master franchise investment | State: ₹1 Cr - 2 Cr |
| Other investment | ₹2 Cr |
| Franchise fee | ₹25L |
| Royalty fee | 20% |
| Payback period | 2–3 months |
| Expected ROI | 35% |
| Space required | 1000 - 35000 sq ft |
| Property types | Commercial |
| Agreement term | 5 years (renewable) |
| Exclusive territory | Yes |
| Training provided | Yes |
|---|---|
| Training location | Pune |
| Operating manual | Yes |
| IT support | Yes |
| Opportunity type | Franchise |
|---|---|
| Franchise model | Unit, Multiunit |
| Headquarter | Pune, Maharashtra |
| Established | 2023 |
| Franchising since | 2024 |
| Franchise outlets | Less than 10 |
The 22Neuro franchise requires an investment of ₹1 Cr - 2 Cr. Listed terms include franchise fee: ₹25L and royalty: 20%. Confirm the current figures with the brand before committing.
The 22Neuro outlet needs 1000 - 35000 sq ft of space.
22Neuro has less than 10 outlets.
22Neuro is headquartered in Pune, Maharashtra. The brand was established in 2023.
22Neuro is looking to expand in Andaman and Nicobar Islands, Andhra Pradesh and Arunachal Pradesh and 32 more locations.
The listed royalty fee for 22Neuro is 20%.
The brand lists a payback period of 2–3 months.
22Neuro lists training, an operating manual and IT support for franchisees. Training takes place at Pune.
The agreement term is 5 years and is renewable.
Use the “I'm interested” button on this page to send an enquiry. Your details are shared with 22Neuro so its team can contact you about the opportunity.
Last updated . Information is compiled from public sources and brand submissions and may change — verify the details with 22Neuro before investing.


